share_log

药康生物(688046.SH)股东青岛国药完成减持141.02万股

Shareholder Qingdao Guoyao of Yaokang Biology (688046.SH) completed the reduction of 1.4102 million shares.

Zhitong Finance ·  Oct 8 17:01

Yao Kang Biology (688046.SH) announced that the company's shareholder Qingdao Guoyao Venture Capital Investment Partnership Enterprise (Limited Partnership)...

According to the Zhitong Finance APP, Yao Kang Biology (688046.SH) announced that the company's shareholder Qingdao Guoyao Venture Capital Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao Guoyao") has cumulatively reduced its shareholding by 1.4102 million shares through block trades, accounting for 0.3439% of the total share capital of the company. The shareholding plan for this period has expired.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment